118 related articles for article (PubMed ID: 10706074)
21. In vivo migration of tonsil lymphocytes in rheumatoid synovial tissue engrafted in SCID mice: involvement of LFA-1.
Jorgensen C; Couret I; Canovas F; Bologna C; Brochier J; Reme T; Sany J
Autoimmunity; 1996; 24(3):179-85. PubMed ID: 9020410
[TBL] [Abstract][Full Text] [Related]
22. Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice.
Naito S; Okada Y; Takahashi M; Kato H; Taneichi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma K; Onodera H; Inoue M; Takahashi Y; Yamazaki S; Kimura H; Komuro K; Uchida T
Int Arch Allergy Immunol; 2000 Oct; 123(2):149-54. PubMed ID: 11060487
[TBL] [Abstract][Full Text] [Related]
23. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
24. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
[TBL] [Abstract][Full Text] [Related]
25. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
[TBL] [Abstract][Full Text] [Related]
26. The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion.
Davies TF; Kimura H; Fong P; Kendler D; Shultz LD; Thung S; Martin A
Clin Immunol Immunopathol; 1991 Aug; 60(2):319-30. PubMed ID: 2070573
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
28. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
29. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
30. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.
Cao T; Leroux-Roels G
Clin Exp Immunol; 2000 Oct; 122(1):117-23. PubMed ID: 11012627
[TBL] [Abstract][Full Text] [Related]
31. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
Tissot JD; Schneider P; Schapira M; Duchosal MA
Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
[TBL] [Abstract][Full Text] [Related]
32. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
[TBL] [Abstract][Full Text] [Related]
33. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
34. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
[TBL] [Abstract][Full Text] [Related]
35. Growth of primary T-cell non-Hodgkin's lymphomata in SCID-hu mice: requirement for a human lymphoid microenvironment.
Waller EK; Kamel OW; Cleary ML; Majumdar AS; Schick MR; Lieberman M; Weissman IL
Blood; 1991 Nov; 78(10):2650-65. PubMed ID: 1824259
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic role of tonsillar lymphocytes in associated with HSP60/65 in Pustulosis palmaris et plantaris.
Hayashi M; Fujihara K; Beder LB; Yamamoto Y; Hotomi M; Yamanaka N
Auris Nasus Larynx; 2009 Oct; 36(5):578-85. PubMed ID: 19268507
[TBL] [Abstract][Full Text] [Related]
37. The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice.
Zhang L; Liu Y; Wang X; Tang Z; Li S; Hu Y; Zong X; Wu X; Bu Z; Wu A; Li Z; Li Z; Huang X; Jia L; Kang Q; Liu Y; Sutton D; Wang L; Luo L; Ji J
Sci Rep; 2015 Mar; 5():9447. PubMed ID: 25819560
[TBL] [Abstract][Full Text] [Related]
38. Human T-and B-cell functions in SCID-hu mice.
Roncarolo MG; Carballido JM; Rouleau M; Namikawa R; de Vries JE
Semin Immunol; 1996 Aug; 8(4):207-13. PubMed ID: 8883143
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
[TBL] [Abstract][Full Text] [Related]
40. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
